Plus Therapeutics (PSTV) Misses Q1 EPS by 75c

Plus Therapeutics (NASDAQ: PSTV) reported Q1 EPS of ($0.75). Revenue for the quarter came in at $1.67 million.

For earnings history and earnings-related data on Plus Therapeutics (PSTV) click here.

You May Also Be Interested In

• Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
• TPU-As-A-Service could boost Google’s 2028 profit by over 15%: Barclays
• HSBC starts SpaceX at Hold, sees execution risks tempering long-term AI ambitions